Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China
10.3389/fphar.2021.717504
Saved in:
Main Authors: | Liu, Jinyu, Zhang, Yu, Wu, Bin, Wang, Sen, Bin-Chia Wu, David, You, Ruxu |
---|---|
Other Authors: | SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH |
Format: | Article |
Published: |
Frontiers Media S.A.
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/233631 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Suppression of hepatitis C virus by hepatitis B virus in coinfected patients at the National University Hospital of Singapore
by: Wang, Y.M., et al.
Published: (2016) -
Suppression of hepatitis C virus by hepatitis B virus in coinfected patients at the National University Hospital of Singapore
by: Wang, Y.M., et al.
Published: (2014) -
How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore
by: Ong, S.C., et al.
Published: (2014) -
The economics of treating chronic hepatitis B in Asia
by: Dan, Y.Y., et al.
Published: (2011) -
Medical and economic burden of chronic hepatitis B patients at Queen Savang Vadhana Memorial Hospital
by: Chuenrutai Yeekian
Published: (2023)